Delivery Order SPE2DB22D1202-SPE2DB25FVDF4

Award Date 6/26/25
Potential Completion Date 6/27/25
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Ketorolac 30 mg/mL vials. The contract has a ceiling value of $2,125.73 and a completion date of September 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical to supply a comprehensive range of medical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of Ketorolac 30 mg/ml vials, a prescription medication. The contract has a ceiling value of $1,326.96 and is a firm-fixed-price delivery order with a completion date of May 28, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a substantial Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $1,124.88, is for the delivery of 4564766828 KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of June 3, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ketorolac 30 mg/ml vial. The contract has a ceiling value of $3,879.20 and a period of performance through February 20, 2025. It is a firm-fixed-price contract and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ketorolac 60 mg/2 ml vials, a specialized medication. The contract has a ceiling value of $1,789.00 and runs through January 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through...
This contract, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, is for the delivery of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has a ceiling value of $2,437.24 and runs through September 9, 2024. It is a Firm Fixed Price Delivery Order contract type, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor responsible for supplying this medication to the DLA, which supports military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ketorolac 30 mg/ml vial. The contract has a firm fixed price, is not set aside, and has a ceiling value of $4,102.92. The ultimate completion date is October 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,326.96, is for the delivery of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of June 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567999126 KETOROLAC 30 MG/ML VIALML, a pain management pharmaceutical product. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $1,163.76 and an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ketorolac 60 mg/2 ml vials, a pain management pharmaceutical product. The contract has a ceiling value of $3,979.25 and a performance period through July 3, 2025. This is a firm fixed-price contract with no set-aside designation, indicating open competition....
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FVDF4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KETOROLAC 30 MG/ML VIALML, with a ceiling value of $25,342.53 and a performance period through June 27, 2025. The contract is a firm fixed-price arrangement and is not set aside for any specific business type.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/25/25, 11:05 AM